With the stock now more than cut in half from its 52-week high, the company recently laid out a plan for its business at its ...

Moderna’s stock has seen an extended downtrend since peaking above $480 in late 2021. After crashing to below $70 in November last year, the stock experienced a strong medium-term rally that took it ...

Delving into the details, we found 45% of traders were bullish, while 36% showed bearish tendencies. Out of all the trades we ...

Shares of Moderna tumbled early Thursday after the vaccine developer said it was cutting research and development spending and pushed back its time frame for breaking even.

The vaccine manufacturer Moderna reported in the journal Cell that a messenger RNA-based mpox vaccine that it is developing ...

Citing skyrocketing COVID spread, the FDA announced in late August that it had approved Pfizer’s Comirnaty and Moderna’s ...

Focuses on ten product approvals through 2027Expects to submit next-generation COVID vaccine for approval in 2024Expects to submit flu/COVID combination vaccine for approval in 2024Announces positive ...

Shares 20+ Year Treasury Bond ETF is breaking higher in anticipation of the rate cut cycle. Click here to see why TLT is a ...

The AMA Update covers a range of health care topics affecting the lives of physicians and patients. Learn more about the latest in bird flu, mpox and COVID vaccines.

The severe disease of the face has finally been recognized as a neglected tropical disease. A heightened focus could help to ...

The alternative rock band Jane's Addiction has scuttled its latest tour following an onstage scuffle between lead singer ...